@article{b0901e3596944727888042ac23471ab2,
title = "Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance",
abstract = "Progesterone-receptor membrane component 1 (PGRMC1/Sigma-2 receptor) is a haem-containing protein that interacts with epidermal growth factor receptor (EGFR) and cytochromes P450 to regulate cancer proliferation and chemoresistance; its structural basis remains unknown. Here crystallographic analyses of the PGRMC1 cytosolic domain at 1.95 {\AA} resolution reveal that it forms a stable dimer through stacking interactions of two protruding haem molecules. The haem iron is five-coordinated by Tyr113, and the open surface of the haem mediates dimerization. Carbon monoxide (CO) interferes with PGRMC1 dimerization by binding to the sixth coordination site of the haem. Haem-mediated PGRMC1 dimerization is required for interactions with EGFR and cytochromes P450, cancer proliferation and chemoresistance against anti-cancer drugs; these events are attenuated by either CO or haem deprivation in cancer cells. This study demonstrates protein dimerization via haem-haem stacking, which has not been seen in eukaryotes, and provides insights into its functional significance in cancer.",
author = "Yasuaki Kabe and Takanori Nakane and Ikko Koike and Tatsuya Yamamoto and Yuki Sugiura and Erisa Harada and Kenji Sugase and Tatsuro Shimamura and Mitsuyo Ohmura and Kazumi Muraoka and Ayumi Yamamoto and Takeshi Uchida and So Iwata and Yuki Yamaguchi and Elena Krayukhina and Masanori Noda and Hiroshi Handa and Koichiro Ishimori and Susumu Uchiyama and Takuya Kobayashi and Makoto Suematsu",
note = "Funding Information: X-ray crystallographic data was collected at the BL-41XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2011B1229, 2012A1184 and 2012B1253). This work was supported by the Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO) Suematsu Gas Biology Project (to M.S.). The present affiliation of M.S. is President, Japan Agency for Medical Research and Development (AMED). Mass spectrometry infrastructure in this work was partly supported by AMED-CREST (to Y.K.), and Platform for Drug Discovery, Informatics, and Structural Life Science from the ministry of Education, Culture, Sports, Science and Technology, Japan (T.K.).",
year = "2016",
month = mar,
day = "18",
doi = "10.1038/ncomms11030",
language = "English",
volume = "7",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
}